港股荣昌生物（09995.HK）今日盘中大涨5.24%，引发市场关注。
根据联交所最新权益披露资料显示，国际知名保险和资产管理集团安联保险（Allianz SE）于4月16日大举增持荣昌生物。安联保险在场内以平均价33.9181港元增持257.55万股荣昌生物股票，涉资约8735.61万港元。此次增持后，安联保险持有荣昌生物的股份数量增至1106.05万股，持股比例从4.48%上升至5.83%。
分析人士认为，安联保险作为国际知名机构投资者大幅增持荣昌生物股份，表明其对公司未来发展前景持积极态度，这极大提振了市场信心。荣昌生物是一家创新型生物制药公司，专注于抗体药物的研发和商业化。机构投资者的青睐可能反映出市场对公司在生物医药领域的创新能力和增长潜力的认可，从而推动股价上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.